Rating History for NovoCure Ltd. (NVCR) by Oppenheimer
Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|
2/2/2022 | Kevin DeGeeter | Upgrade | Outperform (Perform) |
98.00 (N/A) |
71.79 (12.34) |
-82.81% | Details |
Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|
2/2/2022 | Kevin DeGeeter | Upgrade | Outperform (Perform) |
98.00 (N/A) |
71.79 (12.34) |
-82.81% | Details |